Aaseth J, Skalny AV, Roos PM, Alexander J, Aschner M, Tinkov AA (2021) Copper, iron, selenium and lipo-glycemic dysmetabolism in Alzheimer’s disease. Int J Mol Sci 22(17):9461
Article PubMed PubMed Central Google Scholar
Acevedo K, Masaldan S, Opazo CM, Bush AI (2019) Redox active metals in neurodegenerative diseases. J Biol Inorg Chem 24(8):1141–1157
Agnello L, Colletti T, Lo Sasso B, Vidali M, Spataro R, Gambino CM, Giglio RV, Piccoli T, Bivona G, La Bella V, Ciaccio M (2021) Tau protein as a diagnostic and prognostic biomarker in amyotrophic lateral sclerosis. Eur J Neurol 28(6):1868–1875
Agrawal I, Lim YS, Ng SY, Ling SC (2022) Deciphering lipid dysregulation in ALS: from mechanisms to translational medicine. Transl Neurodegener 11(1):48
Article PubMed PubMed Central Google Scholar
Andrew A, Zhou J, Gui J, Harrison A, Shi X, Li M, Guetti B, Nathan R, Tischbein M, Pioro E, Stommel E, Bradley W (2022) Airborne lead and polychlorinated biphenyls (PCBs) are associated with amyotrophic lateral sclerosis (ALS) risk in the US. Sci Total Environ 819:153096
Article PubMed PubMed Central Google Scholar
Arai T, Hasegawa M, Akiyama H, Ikeda K, Nonaka T, Mori H, Mann D, Tsuchiya K, Yoshida M, Hashizume Y, Oda T (2006) TDP-43 is a component of ubiquitin-positive tau-negative inclusions in frontotemporal lobar degeneration and amyotrophic lat-eral sclerosis. Biochem Biophys Res Commun 351(3):602–611
Blasco H, Veyrat Durebex C, Bocca C, Patin F, Vourc’H P, Kouassi Nzoughet J, Lenaers G, Andres CR, Simard G, Corcia P, Reynier P (2017) Lipidomics reveals cerebrospinal-fluid signatures of ALS. Sci Rep 7(1):17652
Article PubMed PubMed Central Google Scholar
Brooks BR, Miller RG, Swash M, Munsat TL (2000) El escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord 1(5):293–299
Cedarbaum JM, Stambler N, Malta E, Fuller C, Hilt D, Thurmond B, Nakanishi A, BDNF ALS Study Group (Phase III) (1999) The ALSFRS-R: a revised ALS functional rating scale that incorporates assessments of respiratory function. J Neurol Sci 169(1–2):13–21
Chen QY, Wu P, Wen T, Qin X, Zhang R, Jia R, Jin J, Hu F, Xie X, Dang J (2022) Association of cerebral spinal fluid copper im-balance in amyotrophic lateral sclerosis. Front Aging Neurosci 14:970711
Article PubMed PubMed Central Google Scholar
Cheng Y, Chen Y, Shang H (2021) Aberrations of biochemical indicators in amyotrophic lateral sclerosis: a systematic review and meta-analysis. Transl Neurodegener 10(1):3
Article PubMed PubMed Central Google Scholar
Chio A, Mora G, Leone M, Mazzini L, Cocito D, Giordana MT, Bottacchi E, Mutani R (2002) Early symptom progression rate is related to ALS outcome: a prospective population-based study. Neurology 59(1):99–103
Chio A, Calvo A, Ilardi A, Cavallo E, Moglia C, Mutani R, Palmo A, Galletti R, Marinou K, Papetti L, Mora G (2009) Lower serum lipid levels are related to respiratory impairment in patients with ALS. Neurology 73(20):1681–1685
Cozzolino M, Carri MT (2012) Mitochondrial dysfunction in ALS. Prog Neurobiol 97(2):54–66
Dantas LS, Chaves-Filho AB, Coelho FR, Genaro-Mattos TC, Tallman KA, Porter NA, Augusto O, Miyamoto S (2018) Cholesterol secosterol aldehyde adduction and aggregation of Cu, Zn-superoxide dismutase: potential implications in ALS. Redox Bi-Ol 19:105–115
de la Rubia Ortí JE, Armero JLP, Sanchis-Sanchis CE, Sancho-Castillo S, Salazar A, Caplliure-Llopis J, Navarro-Illana E, Barrios C, Escribá-Alepuz J, Benlloch M (2021) Muscle function differences between patients with bulbar and spinal onset amyotrophic lateral sclerosis. Does it depend on peripheral glucose? J Clin Med 10(8):1582
Article PubMed PubMed Central Google Scholar
DeJesus-Hernandez M, Mackenzie IR, Boeve BF, Boxer AL, Baker M, Rutherford NJ, Nicholson AM, Finch NA, Flynn H, Adamson J, Kouri N, Wojtas A, Sengdy P, Hsiung GY, Karydas A, Seeley WW, Josephs KA, Coppola G, Geschwind DH, Wszolek ZK, Feldman H, Knopman DS, Petersen RC, Miller BL, Dickson DW, Boylan KB, Graff-Radford NR, Rademakers R (2011) Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS. Neuron 72(2):245–256
Article PubMed PubMed Central Google Scholar
Delaye JB, Patin F, Piver E, Bruno C, Vasse M, Vourc’H P, Andres CR, Corcia P, Blasco H (2017) Low IDL-B and high LDL-1 subfraction levels in serum of ALS patients. J Neurol Sci 380:124–127
Deng HX, Hentati A, Tainer JA, Iqbal Z, Cayabyab A, Hung WY, Getzoff ED, Hu P, Herzfeldt B, Roos RP, Et A (1993) Amyotrophic lateral sclerosis and structural defects in Cu. Zn Superoxide Dismutase Science 261(5124):1047–1051
Dickerson AS, Hansen J, Specht AJ, Gredal O, Weisskopf MG (2019) Population-based study of amyotrophic lateral sclerosis and occupational lead exposure in Denmark. Occup Environ Med. https://doi.org/10.1136/oemed-2018-105469
Dickerson AS, Hansen J, Gredal O, Weisskopf MG (2020) Study of occupational chromium, iron, and nickel exposure and amyotrophic lateral sclerosis in Denmark. Int J Environ Res Public Health 17(21):8086
Article PubMed PubMed Central Google Scholar
Dresser L, Wlodarski R, Rezania K, Soliven B (2021) Myasthenia gravis: epidemiology, pathophysiology and clinical manifestations. J Clin Med. https://doi.org/10.3390/jcm10112235
Article PubMed PubMed Central Google Scholar
Fan K, Jia X, Zhou M, Wang K, Conde J, He J, Tian J, Yan X (2018) Ferritin nanocarrier traverses the blood brain barrier and kills glioma. ACS Nano 12(5):4105–4115
Fang F, Peters TL, Beard JD, Umbach DM, Keller J, Mariosa D, Allen KD, Ye W, Sandler DP, Schmidt S, Kamel F (2017) Blood lead, bone turnover, and survival in amyotrophic lateral sclerosis. Am J Epidemiol 186(9):1057–1064
Article PubMed PubMed Central Google Scholar
Farace C, Fenu G, Lintas S, Oggiano R, Pisano A, Sabalic A, Solinas G, Bocca B, Forte G, Madeddu R (2020) Amyotrophic lateral sclerosis and lead: a systematic update. Neurotoxicology 81:80–88
Fautsch KJ, Block DR, Graff-Radford J, Wang F, Craver EC, Hodge DO, Cutsforth-Gregory JK, Kilgore KP, Petersen RC, Knopman DS, Flanagan E, Toledano M, Mielke MM, Bhatti MT, Chen JJ (2023) Population-based evaluation of total protein in cerebrospinal fluid. Mayo Clin Proc 98(2):239–251
Feldman EL, Goutman SA, Petri S, Mazzini L, Savelieff MG, Shaw PJ, Sobue G (2022) Amyotrophic lateral sclerosis. Lancet 400(10360):1363–1380
Article PubMed PubMed Central Google Scholar
Forte G, Bocca B, Oggiano R, Clemente S, Asara Y, Sotgiu MA, Farace C, Montella A, Fois AG, Malaguarnera M, Pirina P, Madeddu R (2017) Essential trace elements in amyotrophic lateral sclerosis (ALS): results in a population of a risk area of Italy. Neurol Sci 38(9):1609–1615
Gil-Bea FJ, Aldanondo G, Lasa-Fernández H, López De Munain A, Vallejo-Illarramendi A (2017) Insights into the mechanisms of copper dyshomeostasis in amyotrophic lateral sclerosis. Expert Rev Mol Med 19:e7
Grober U, Schmidt J, Kisters K (2015) Magnesium in prevention and therapy. Nutrients 7(9):8199–8226
Article PubMed PubMed Central Google Scholar
Hop PJ, Zwamborn RA, Hannon E et al (2022) Genome-wide study of DNA methylation shows alterations in metabolic, inflammatory, and cholesterol pathways in ALS. Sci Transl Med 14(633):eabj0264
Article PubMed PubMed Central Google Scholar
Jang D, Dou J, Koubek E, Teener S, Zhou L, Bakulski K, Mukherjee B, Batterman S, Feldman E, Goutman S (2025) Multiple metal exposures associate with higher amyotrophic lateral sclerosis risk and mortality independent of genetic risk and correlate to self-reported exposures: a case-control study. J Neurol Neurosurg Psychiatry 96(4):329–339
Comments (0)